Results 201 to 210 of about 38,804 (257)

Investigation of hyperhomocysteinemia

Annales de biologie clinique, 2013
Hyperhomocysteinemia has been described as a risk factor for venous and arterial thromboembolic diseases but may be also involved in neurodegenerative and neuropsychiatric disorders. Considering some arguments for homocysteine (Hcy) toxicity, a systematic investigation tool of hyperhomocysteinemia is needed.
Charlotte, Veyrat-Durebex, Hélène, Blasco, Julie, Crinier, Caroline, Vayne, Patrick, Emond, François, Labarthe, Christian R, Andres, François, Maillot   +7 more
openaire   +2 more sources

Hyperhomocysteinemia and Restenosis

European Journal of Cardiovascular Prevention & Rehabilitation, 2001
This study was undertaken to assess the effect of plasma homocysteine level on angiographic restenosis 6 months after coronary angioplasty.The plasma homocysteine level was measured in 100 consecutive patients at the time of coronary angioplasty, 56 patients who attended a 6-month follow-up angiogram being enrolled to the study; the 44 patients without
S D, Kumbasar, I, Dinçer, F, Ertas, S, Gülec, C, Erol, O, Akyürek, M, Kiliçkap, D, Oral, E, Sipahi, Y, Laleli   +9 more
openaire   +2 more sources

Homocysteine, hyperhomocysteinemia and H-type hypertension.

European Journal of Preventive Cardiology
Homocysteine (Hcy) is a sulfur-containing nonessential amino acid derived from the intermediate metabolites of methionine. Methionine is obtained from dietary proteins, such as poultry, meat, eggs, seafood, and dairy products.
Dong-Feng Wu, Rui-Xing Yin, Jin-Long Deng   +2 more
semanticscholar   +1 more source

Interaction of smoking, hyperhomocysteinemia, and metabolic syndrome with carotid atherosclerosis: A cross-sectional study in 972 non-diabetic patients.

Nutrition (Burbank, Los Angeles County, Calif.), 2020
OBJECTIVES Little is known about the interactions between hyperhomocysteinemia and metabolic syndrome (MetS) in individuals at risk for atherosclerosis.
M. R. Azarpazhooh, M. Andalibi, D. Hackam, J. Spence   +3 more
semanticscholar   +1 more source

Hyperhomocysteinemia

The APRN and PA’s Complete Guide to Prescribing Drug Therapy, 2019
S. Choi, J. H. Park, J.-S. Song, E. Kang, K.-H. Lee, S. K. Rai, N. Lu, C. Yokose, H. K. Choi   +8 more
semanticscholar   +3 more sources

Hyperhomocysteinemia

2006
Abstract A 35-year-old man presented to his family physician after he noted a 20-min episode of slurred speech and weakness of his left arm. He had had a similar episode, lasting 10 min, 3 days earlier. He had never smoked cigarettes, and he had no history of high blood pressure, high cholesterol, diabetes, stroke, or neurological ...
Angela M Devlin, Steven R Lentz
openaire   +1 more source

Hyperhomocysteinemia and thrombosis

Hematology/Oncology Clinics of North America, 2003
Homocysteine remains an enigmatic marker for vascular disease. Studies have shown hyperhomocysteinemia is a risk factor for VTE, cerebrovascular disease, and coronary artery disease. This relationship, however, has not been consistently corroborated by studies of patients with genetic polymorphisms that alter homocysteine metabolism.
Ray, Lee, Eugene P, Frenkel
openaire   +2 more sources

Management of Hyperhomocysteinemia

Metabolic Syndrome and Related Disorders, 2003
Hyperhomocysteinemia is an established risk factor for cardiovascular disease. The modification of traditional cardiovascular risk factors has resulted in better morbidity and mortality outcomes, so the treatment of hyperhomocysteinemia is explored for a similar benefit.
Emily, Chan, Vivian A, Fonseca
openaire   +2 more sources

Hyperhomocysteinemia and Thrombosis

Seminars in Thrombosis and Hemostasis, 1999
Homocysteine has been identified as an independent risk factor for atherosclerotic and thrombotic disease. Both arterial (cerebrovascular, carotid, coronary, and peripheral arterial) and veno-occlusive disease, jointly termed vascular occlusive disease (VOD) in this review, have been associated with hyperhomocysteinemia.
S C, Guba, V, Fonseca, L M, Fink
openaire   +2 more sources

Hyperhomocysteinemia in dementia

Journal of Neural Transmission, 2000
Hyperhomocysteinemia is a strong risk factor for atherosclerotic vascular disease, and elevated serum homocysteine is correlated with vitamin B deficiency. In this pilot study, significantly elevated homocysteine levels were found in patients with Alzheimer's disease as well as in patients with vascular dementia, probably indicating similar ...
F, Leblhuber, J, Walli, E, Artner-Dworzak, K, Vrecko, B, Widner, G, Reibnegger, D, Fuchs   +6 more
openaire   +2 more sources